Induction of endogenous Bcl-xS through the control of Bcl-x pre-mRNA splicing by antisense oligonucleotides-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Induction of endogenous Bcl-xS through the control of Bcl-x pre-mRNA splicing by antisense oligonucleotides

Published:1999-11 Issue:11 Volume:17 Page:1097-1100
ISSN:1087-0156
Container-title:Nature Biotechnology
language:en
Short-container-title:Nat Biotechnol

Author:

Taylor Jennifer K.,Zhang Qing Qing,Wyatt Jacqueline R.,Dean Nicholas M.

Publisher

Springer Science and Business Media LLC

Subject

Biomedical Engineering,Molecular Medicine,Applied Microbiology and Biotechnology,Bioengineering,Biotechnology

Link

http://www.nature.com/articles/nbt1199_1097.pdf

Reference32 articles.

1. Raff, M. Cell suicide for beginners. Nature 396, 119– 122 (1998).

2. White, E. Life, death, and the pursuit of apoptosis. Genes Dev. 10, 1–15 (1996).

3. Jiang, Z-H. & Wu, J.Y. Alternative splicing and programmed cell death. Proc. Soc. Exp. Biol. Med. 220, 64–72 (1999).

4. Boise, L.H. et al. Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74, 597– 608 (1993).

5. Yang, E. & Korsmeyer, S.J. Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood 88, 386–401 (1996).

Cited by 183 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the conserved active site of splicing machines with specific and selective small molecule modulators;Nature Communications;2024-06-19

2. Targeting the conserved active site of splicing machines with specific and selective small molecule modulators;2023-06-22

3. RNA splicing dysregulation and the hallmarks of cancer;Nature Reviews Cancer;2023-01-10

4. Inhibition of Epidermal Growth Factor Receptor Signaling by Antisense Oligonucleotides as a Novel Approach to Epidermal Growth Factor Receptor Inhibition;Nucleic Acid Therapeutics;2022-10-01

5. Development of a Prognostic Alternative Splicing Signature Associated With Tumor Microenvironment Immune Profiles in Lung Adenocarcinoma;Frontiers in Oncology;2022-06-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3